Relationship between human leukocyte antigen determinants and courses of hepatitis B virus infection in Caucasian patients with end-stage renal disease

Scandinavian Journal of Gastroenterology

Volumn 31, Issue 12, 1996, Pages 1211-1215

  Chen, D F ^a   Kliem, V ^b   Endres, W ^b   Brunkhorst, R ^b   Tillmann, H L ^b   Koch, K M ^b   Manns, M P ^b   Stangel, W ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NONE

Author keywords

End stage renal disease; Hepatitis B; Human leukocyte antigen

Indexed keywords

EPITOPE; HLA ANTIGEN;

ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; HEPATITIS B; HUMAN; INFECTION SENSITIVITY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0029851924     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529609036912     Document Type: Article

References (19)

1. Kaslow RA, Shaw S. The role of histocompatibility antigens (HLA) in infection. Epidemiol Rev 1981;3:90-114.
2. Lepage V, Degos F, Carella G, De Lima M, Giraud MC, Degos L. HLA-Cw7 and HBsAg negative chronic active hepatitis. Tissue Antigens 1981;18:105-7.
3. Carhonara A, Mayr, W, Rizzetto M, Contu L, Curtoni ES, DeMarchi M, et al. Endemic HBV infection, tissue autoantibodies and HLA. Tissue Antigens 1983;22:289-94.
4. Forzani B, Actis GC, Verme G, Amoroso A, Borelli I, Curtoni ES, et al. HLA-DR antigens in HBsAg-positive chronic active liver disease with and without associated delta infection. Hepatology 1984;4:1107-10.
5. Mota AH, Fainhoim H, Terg R, Fainhoim L. Association of chronic active hepatitis and HLA B35 in patients with hepatitis B virus. Tissue Antigens 1987;30:238-40.
6. Van Hattum J, Schreuder GMT, Schalm SW. HLA antigens in patients with various courses after hepatitis B virus infection. Hepatology 1987;7:11-4.
7. Almarri A, Batchelor JR. HLA and hepatitis B infection. Lancet 1994;344:1194-5.
8. Verdon R, Pol S, Landais P, Mattlinger B, Carnot F, Brechot C, et al. Absence of association between HLA antigens and chronicity of viral hepatitis in haemodialyzed patients. J Hepatol 1994;21:388-93.
9. Thursz MR, Kwiatkowski D, Allsopp CEM, Greenwood BM, Thomas HC, Hill AVS. Association between an MHC class II allele and clearance of hepatitis B virus. N Engl J Med 1995; 332:1065-9.
10. Chen D, Endres W, Münz M, Müller R, Meyer AS, Robin-Winn M, et al. HLA-Klasse-II-Typisierung mittels RFLP mit Digoxigenin-markierten Sonden: Vergleich mit serologischer Typisierung bei 309 Personen. Infusionsther Transfusionsmed 1992;19: 302.
11. Mytilineos J, Seherer S, Opelz G. Comparison of RFLP-DR beta and serological HLA-DR typing in 1500 individuals. Transplantation 1990;50:870-3.
12. Chen DF, Endres W, Meyer SA, Stangel W. A polymerase chain reaction-sequence-specific oligonucleotide procedure for HLA class II typing using biotin- and digoxigenin-labeled probes simultaneously in hybridization. Hum Immun 1994;39:25-30.
13. Chen DF, Endres W, Meyer SA, Stangel W. Simplified PCR-SSO procedure for DQA and DQB typing - simultaneous hybridization of two probes to one membrane. Hum Immunol 1996;46:120-3.
14. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992;39:225-35.
15. Svejgaard A, Ryder LP. HLA and disease associations: detecting the strongest association. Tissue Antigens 1994;43:18-27.
16. Hill AVS, Allsopp CEM,. Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA, et al. Common West African HLA antigens are associated with protection from severe malaria. Nature 1991;352:595-600.
17. Kaslow RA, Shaw S. The role of histocompatibility antigens (HLA) in infection. Epidemiol Rev 1981;3:90-114.
18. Yang PM, Sung JL, Chen DS, HLA-A, B, C and DR antigens in chronic hepatitis B viral infection. Hepatogastroenterology 1989;36:363-6.
19. Pol S, Legendre C, Mattlinger B, Berthelot P, Kreis H. Genetic basis of nonresponse to hepatitis B vaccine in hemodialyzed patients. J Hepatol 1990;11:385-7.